Home >> Report Store >> Healthcare >> Antifungal Drugs Market Size, Share, Global Industry Report, 2018-2025 >

Antifungal Drugs Market, By Types (Azoles, Echinocandins, Polyenes, and Allylamines), By Indication (Dermatophytosis, Aspergillosis, and Candidiasis), And Geography (North America, Europe, Asia Pacific, And Rest Of The World) – Analysis, Share, Trends, Size, & Forecast From 2014 – 2025

138 Pages | Published Date : 20 / 08 / 17  | Report Code: AV106 | Report Format: PDF

REPORT HIGHLIGHT The antifungal drugs market is estimated to represent a global market of USD 13.8 billion by 2025 with growth rate of 1.9%. Market Dynamics Earlier, serious fungal infections were very uncommon, particularly due to the cool temperature. Fungal infections means usual discomfort or hardly it was the life threatening during those days. However, there has been steady increase in incidence rate of fungal diseases during the past few years. One of the factors aiding the spread of these diseases was to rising number of patient population susceptible to fungal infections. For example, yearly incidence of invasive infections of Candida is estimated at around 400,000 cases per year, of which 98,000 cases are reported in the US alone. This shows the potential threat to human health. Commonly systemic fungal infection is due to yeast-like organism is the widespread among patient population. Other more serious fungal problems are invasive pulmonary aspergillosis, cryptococcal meningitis or endocarditis, and rhinocerebral mucormycosis. Among which, invasive pulmonary aspergillosis is considered to be the leading cause of death in many countries (developed as well as developing). Patients with compromised immunity, extensive medical stays, catheterization for a long time or under organ transplantation are more susceptible toward these types of infections. Other factors such as growing geriatric population, rising research and development activities, technological advancements and development of novel antifungal therapeutics are expected to surge in demand for uptake of antifungal drugs. Additionally, growing awareness amongst the patients and healthcare professionals is anticipated to propel the demand for this antifungal agent in coming years. Further, presence of unmet need for safe & effective antifungals to treat antifungal disorders is considered to be a key factor attributing toward the market growth over the forecast period. However, availability of alternative treatment options such as herbal medicines and narrow product pipeline for the treatment are expected to limit the growth of antifungal drugs to treat candidiasis. Fungal infection treatment could be systemic or topical. Of which, topical antifungal treatment is considered to be the first line treatment therapy for superficial, uncomplicated and localized infections. This treatment therapy offers high efficacy and low adverse event to the patients. On other side, systemic agents are delivered to the body tissues by vascular systems. Oral route is usually considered to be the safe, easy and economical route for antifungal drug delivery. However, patient’s choice involve based on drug formulation and other product variables. Types Takeaway Antifungal drugs are divided in terms of Azoles, Echinocandins, Polyenes, Allylamines and others. Azole antifungal drugs act by inhibiting the enzyme that allows fungi to develop. This segment is considered to be the largest market segment and hold dominant position during the forecast period. Azoles are commercialized by brands such as Noxafil, Vfend, and Diflucan. We understood that although above brands hold larger shares, generic penetration is expected to be high and continues to rise. As of 2016, azoles drug class captured 4,326 million revenue and is expected to grow with 0.1% growth rate. Echinocandins is the highest growing drug class in antifungal treatment, with 4.2% CAGR during the forecast period. Indication Takeaway In terms of indication, the market divided as Dermatophytosis, Aspergillosis, Candidiasis and Others. Candidiasis segment hold largest revenue and is expected to maintain its dominant position in future. Regionally, the market analyzed in terms of North America, Europe, Asia Pacific, Latin America and Middle East and Africa. Developed regions accounted for the largest share owing to the rise in research and development activities in this area. North America (U.S.) recorded almost 35% share of the total market in 2016. Key Vendor Takeaway Antifungal drugs market is fragmented in nature, characterized by the presence of the several generic products in the treatment. Widespread presence of this infection resulted in dynamic changes in this market. These infections are recurrent in nature and there is limited availability of safe & effective options. These factors are anticipated to propel the research in this field which thereby resulted in high market penetration of new antifungal products in coming years. Giant players such as Pfizer, Inc., Novartis AG, Sanofi-Aventis, Merck, Bayer AG, and GlaxoSmithKline exhibit their potential in this market. These drug manufacturers are focusing on the development of early and rapid diagnostic options to detect fungal problems. Generic competition in very strong in this market, with more than 60% share of the market captured by generic pharmaceuticals. This leave handful of brand drugs to exhibit its significant position in this market. Increasing generic competition coupled with most competitive environment among key players is considered to rise the barriers for new entrants as well as to new product approval. However, we expect that new approval in brand as well as generic version will continue to show significant role for the market development. The market size and forecast for each segment has been provided for the period 2014 to 2025, considering 2015 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2016 to 2025 for every reported segment. The years considered for the study are:

  • Historical Year – 2014 & 2015
  • Base Year – 2015
  • Estimated Year – 2016
  • Projected Year – 2025

TARGET AUDIENCE

  • Traders, Distributors, And Suppliers
  • Manufacturers
  • Hospitals
  • Government and Regional Agencies and Research Organizations
  • Consultants
  • Distributors

SCOPE OF THE REPORT The scope of this report covers the market by its major segments, which include as follows: MARKET, BY TYPES

  • Azoles
  • Echinocandins
  • Polyenes
  • Allylamines
  • others

MARKET, BY INDICATION

  • Dermatophytosis
  • Aspergillosis
  • Candidiasis
  • Others

MARKET, BY REGION

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

MARKET, BY COUNTRY

  • Further Breakdown of The North America Market
    • U.S.
    • Canada
  • Further Breakdown of The Europe Market
    • Germany
    • France
    • Rest of Europe
  • Further Breakdown of The APAC Market
    • India
    • China
    • Rest of APAC
  • Further Breakdown of The Rest of the World Market
    • Middle East and Africa
    • Latin America
TABLE OF CONTENT 1. ANTIFUNGAL DRUGS MARKET OVERVIEW 1.1. Study Scope 1.2. Base Year 1.3. Assumption and Methodology 2. EXECUTIVE SUMMARY 2.1. Key Market Facts 2.2. Geographical Scenario 2.3. Companies in the Market 3. ANTIFUNGAL DRUGS KEY MARKET TRENDS 3.1. Market Drivers 3.1.1. Impact Analysis of Market Drivers 3.2. Market Restraints 3.2.1. Impact Analysis of Market Restraints 3.3. Market Opportunities 3.4. Market Future Trends 4. ANTIFUNGAL DRUGS INDUSTRY STUDY 4.1. Company Activity Analysis 4.2. Regulatory Framework Analysis 4.3. Pipeline Analysis 4.4. Value Chain Analysis 5. ANTIFUNGAL DRUGS MARKET LANDSCAPE 5.1. Market Share Analysis 5.2. Key Innovators 6. ANTIFUNGAL DRUGS MARKET – BY TYPES: 6.1. Overview 6.2. Azoles 6.2.1. Overview 6.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million) 6.3. Echinocandins 6.3.1. Overview 6.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million) 6.4. Polyenes 6.4.1. Overview 6.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million) 6.5. Allylamines 6.5.1. Overview 6.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million) 6.6. Others 6.6.1. Overview 6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million) 7. ANTIFUNGAL DRUGS MARKET – BY INDICATION: 7.1. Overview 7.2. Dermatophytosis 7.2.1. Overview 7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million) 7.3. Aspergillosis 7.3.1. Overview 7.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million) 7.4. Candidiasis 7.4.1. Overview 7.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million) 7.5. Others 7.5.1. Overview 7.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million) 8. ANTIFUNGAL DRUGS MARKET– BY GEOGRAPHY 8.1. Introduction 8.2. North America 8.2.1. Overview 8.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million) 8.2.3. U.S. 8.2.3.1. Overview 8.2.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million) 8.2.4. Canada 8.2.4.1. Overview 8.2.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million) 8.3. Europe 8.3.1. Overview 8.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million) 8.3.3. France 8.3.3.1. Overview 8.3.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million) 8.3.4. Germany 8.3.4.1. Overview 8.3.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million) 8.3.5. Rest of Europe 8.3.5.1. Overview 8.3.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million) 8.4. Asia Pacific (APAC) 8.4.1. Overview 8.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million) 8.4.3. China 8.4.3.1. Overview 8.4.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million) 8.4.4. India 8.4.4.1. Overview 8.4.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million) 8.4.5. Rest of APAC 8.4.5.1. Overview 8.4.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million) 8.5. Rest of the World 8.5.1. Overview 8.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million) 8.5.3. Latin America 8.5.3.1. Overview 8.5.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million) 8.5.4. Middle East and Africa 8.5.4.1. Overview 8.5.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million) 9. KEY VENDOR ANALYSIS 9.1. Pfizer, Inc. 9.1.1. Company Overview 9.1.2. SWOT Analysis 9.1.3. Key Developments 9.2. Novartis AG 9.2.1. Company Overview 9.2.2. SWOT Analysis 9.2.3. Key Developments 9.3. Sanofi-Aventis 9.3.1. Company Overview 9.3.2. SWOT Analysis 9.3.3. Key Developments 9.4. Merck 9.4.1. Company Overview 9.4.2. SWOT Analysis 9.4.3. Key Developments 9.5. Bayer AG 9.5.1. Company Overview 9.5.2. SWOT Analysis 9.5.3. Key Developments 9.6. GlaxoSmithKline plc 9.6.1. Company Overview 9.6.2. SWOT Analysis 9.6.3. Key Developments 10. 360 DEGREE ANALYSTVIEW 11. APPENDIX 11.1. Research Methodology 11.2. Abbreviations 11.3. Disclaimer 11.4. Contact Us SCOPE AND OBJECTIVES : The objective of this report is to describe the market trends and revenue forecasts for the market for the upcoming years. The report focuses on defining and describing the key influencing factors for the growth of the market. It also offers an in-depth analysis of the market size (revenue), market share, major market segments, different geographic regions, key market players, and premium industry trends. The report tracks the major market events including product launches, technological developments, mergers & acquisitions, and the innovative business strategies opted by key market players. Along with strategically analysing the key micro markets, the report also focuses on industry-specific drivers, restraints, opportunities and challenges in the coil coatings market. The scope of this report covers the market by its major segments, which include the source, disease end user industry, and the major geographic regions. KEY BENEFITS OF THE REPORT : • Understanding of the strategies that are being adopted by the key players in this market to stay competitive • Extensive analysis of the key players dominating the competitive landscape of this market • In-depth analysis of the key factors are propelling the growth of the global market • Detailed analysis of the geographic region that will witness the strongest growth • Granular analysis of the current market scenario and the expected market grow
RESEARCH METHDOLOGY AnalystView’s research methodology is developed on a combination of specialist industry analyst knowledge and in-country research experience. We employ data interrogation methodologies to generate new and meaningful analyses and insights. The research study involves extensive usage of secondary sources, directories, and databases (such as Hoovers, Bloomberg, and Businessweek) to identify and collect information useful to understand technical, market-oriented, and commercial aspects of market. Market data and information are also collected and not limited to secondary sources like:

  • Official Company’s Website, Financial and Annual Reporting
  • Government Statistical Data
  • Online Publishing Articles
  • Industry Player’s Investor Presentations
  • Economic News Articles
  • National and International Trade Associations
  • The Financial, Business and Mainstream Press
  • Industry Study Groups and Other Semi-Official Sources
  • Many Other Informative Channels Related to the Market Topics
  • * Gathering data through secondary sources is only the first step. The ability to cross-refer market data through available secondary information often conflicting across multiple sources is a key aspect of the added value we provide

In order to verify and validate secondary market data, we engage with a variety of personnel in key players at all points through phone calls, emails and web based survey responses with key opinion leaders (KoL’s) operating in the respective markets. The engagement involves the CEO, vice presidents, top-level and middle-level managers of the company, directors of marketing, product managers, brand managers, customers of major industrial products, and many others. We also interview manufacturers, distributors, materials suppliers, retailers, service operators, study groups, industry associations, and third party observers from the trade and financial press. These obtained information helped us to understand several facets of the market with respect to manufacturers’ and buyers’ perspective. These data were carefully filtered, analyzed, compared and presented in an easy way to develop accurate research study. Furthermore, all collected data is subjected to undergo exhaustive review process at country level, regional level and global level. MARKET FORECAST Market forecast for the respective market is primarily based on the year on year (YOY) growth rate. Data projection and future performance of each segment analyzed based on the key aspects extracted from primary and secondary research results. Thus data projection states the assumption on how the market behaves under macroeconomic and microeconomic parameters. Our market forecasting represents strategic conclusion we have reached about the coming state of the market scenario. MARKET ANALYSIS Another integral part of our research study is that AnalystView’s market data is accompanied by clear written analysis. We include detail information on market segments in terms of market drivers, market restraints and market opportunities. These offer insights of different channel dynamics, brand preference, incidence/prevalence data, technology up gradation, consumption trend, and future market scenario. We also include supporting data with any relevant awareness campaign, new introduction, regulatory norms, government initiatives, and industry player’s expansion in specific product segments. From research perspective, this information explains and substantiates estimated data finding and forecast.

Why AnalystView?

 
Z

Trusted Partnership

We strive to become one of the trusted partner of our client by offering value added services and concrete research data.
Y

Tailor-Made Solutions

From single reports and data downloads to enterprise subscriptions to custom consultancy, we can base our precise solutions round our client’s exact needs.

Turnaround Time

Our analyst aims to provide research studies in quickest turnaround time and in a much cost effective manner.
T

Data Accuracy and Reliability

We utilize a mix of primary, secondary research, and machine learning algorithms to generate accurate and comprehensive data about market size and revenue forecasts.

Competitive Pricing

We offer most competitive pricing policy across the research industry

Client Testimonials

 

Asia Pacific based Chemical Industry (Privacy Requested)

Thanks AnalystView for putting a great team to work on our research projects. It was a smooth transition of knowledge and delivery was seamless. We are keen to work with you on our upcoming projects. Thank you once again for the professional attitude your team has demonstrated.

CEO, Europe based Digital Media Company (Privacy Requested)

We had confusion after receiving the final data sheet of report. As per some preliminary we already have, we believe the market is over estimated.. However, after string of calls with analyst, we found their final research analysis was methodologically sound and their work to be very professional and up […]

Managing Director, Chemical based Company, Asia Pacific (Privacy Requested)

We are happy with the way the AnalystView member understood the brief and went about executing our research project.

U.S. Headquartered Medical Device Company (Privacy Requested)

AnalystView team has done brand assessment study for blood glucose monitoring devices market, in which we want enter into….We were very impressed not only by their research skills but also by their understanding of issues relevant to our requirements…!!

Vice President, Petrochemical Firm based in China (Privacy Requested)

It was a pleasure assigning project to AnalystView; they are reliable, fast and friendly. Highly recommend this company for research workJGood stuff!

US based healthcare service provider (Privacy Requested)

Frankly, we didn’t expect much comprehensive data for the report we purchased. To be surprised, I must say the report we received was very nicely executed….It contains all the information we are looking for and satisfied with the quality of the report. Thank you team

Europe based Chemical Industry (Privacy Requested)

Just wanted to say massive thanks for all the help from the AnalystView team. We purchased two reports one is Food Safety Testing report and another one is Enzyme market. These reports have helped us build a sound knowledge base of our business segments and have taken our business to […]

Why Choose Us

 

We devise research report with quality data:

Combined with an in-depth knowledge of the current industry and a sharp analytical mind, AnalystView serve our customer accurate research in accordance with a constantly evolving industry.

We work with businesses just like yours: 

AnalystView committed to making a positive difference for our clients. This means whatever you demand, chances are we already have experience with something similar.

Share This